カテゴリー： IMARC, 世界, 医療/バイオ

ジェネリック腫瘍治療薬の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測

◆英語タイトル：Generic Oncology Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが発行した調査報告書（IMARC23JLY092）◆商品コード：IMARC23JLY092
◆発行会社（リサーチ会社）：IMARC
◆発行日：2023年7月
◆ページ数：138
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥759,848見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

アイマーク社の本市場調査資料によると、2022年に277億ドルであった世界のジェネリック腫瘍治療薬市場規模が、2028年までに371億ドルに達し、予測期間中（2023-2028）にCAGR 5.7%成長すると予想しています。本資料では、ジェネリック腫瘍治療薬の世界市場について調査・分析し、序論、市場範囲・定義、エグゼクティブサマリー、イントロダクション、市場概況、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、中南米）分析、競争状況、製造プロセス、プロジェクト詳細・要件・関連コスト、融資・財政援助、経済計画などの内容をまとめています。
・序論
・市場範囲・定義
・エグゼクティブサマリー
・イントロダクション
・市場概況
・世界のジェネリック腫瘍治療薬市場規模：地域別
- 北米のジェネリック腫瘍治療薬市場規模
- ヨーロッパのジェネリック腫瘍治療薬市場規模
- アジア太平洋のジェネリック腫瘍治療薬市場規模
- 中東・アフリカのジェネリック腫瘍治療薬市場規模
- 中南米のジェネリック腫瘍治療薬市場規模
・競争状況
・製造プロセス
・プロジェクト詳細・要件・関連コスト
・融資・財政援助
・経済計画

Market Overview:

The global generic oncology drugs market size reached US$ 27.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 37.1 Billion by 2028, exhibiting a growth rate (CAGR) of 5.7% during 2023-2028.

Generic oncology drugs assist in shrinking, controlling and destroying the cancer cells present in the human body. Furthermore, a few oncology drugs are widely prescribed by doctors to alleviate symptoms, including pain. They share the same active ingredients as the already marketed brand-name cancer care medicine. These drugs can be characterized by a different color or flavor than that of the original drug but their quality, performance, intended use, strength, dosage form and route of administration remain the same. Consequently, these drugs efficiently deliver equivalent clinical benefits and yield the same therapeutic effect as their brand-name counterparts at a lower cost.

The escalating prevalence of cancer is one of the key factors driving the market growth. Owing to various factors including a rapid increase in the number of smokers, sedentary lifestyle and excessive exposure to ultraviolet (UV) rays, the number of cancer cases has experienced a significant rise across the globe. In addition to this, the high costs associated with a full-length cancer treatment have led a majority of the patients to opt for these drugs as they are much more cost-effective as compared to their brand-name counterparts. Moreover, patent expiration of key blockbuster drugs is also a significant factor that is providing a boost to the market growth. Along with this, governments of several countries are undertaking initiatives to promote generic drugs. They are continually engaging in research and development (R&D) activities to reduce healthcare expenses related to cancer treatment, thus making the healthcare facility accessible and affordable for all. Such initiatives are augmenting the introduction of several new generic drugs. Other factors such as rising awareness about the benefits of early cancer diagnosis and growing inclination toward preventive measures are contributing to the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global generic oncology drugs market report, along with forecasts at the global and regional level from 2023-2028.

Regional Insights:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Amongst these, North America holds the leading position in the market, owing to an increasing number of cancer patients and rising awareness about early cancer diagnosis.

Competitive Landscape:
The competitive landscape of the market has also been analyzed in the report with the detailed profiles of the key players operating in the market.

Key Questions Answered in This Report
1. What was the size of the global generic oncology drugs market in 2022?
2. What is the expected growth rate of the global generic oncology drugs market during 2023-2028?
3. What has been the impact of COVID-19 on the global generic oncology drugs market?
4. What are the key factors driving the global generic oncology drugs market?
5. What are the key regions in the global generic oncology drugs market?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Generic Drug Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Region
5.4 Market Forecast
6 Global Generic Oncology Drug Market
6.1 Market Overview
6.2 Market Trends
6.3 Impact of COVID-19
6.4 Top Generic Oncology Drugs
6.5 Price Analysis
6.6 Market Forecast
6.7 SWOT Analysis
6.7.1 Overview
6.7.2 Strengths
6.7.3 Weaknesses
6.7.4 Opportunities
6.7.5 Threats
6.8 Value Chain Analysis
6.8.1 Research and Development
6.8.2 Manufacturing
6.8.3 Marketing
6.8.4 Distribution
6.9 Porter’s Five Forces Analysis
6.9.1 Overview
6.9.2 Bargaining Power of Buyers
6.9.3 Bargaining Power of Suppliers
6.9.4 Degree of Competition
6.9.5 Threat of New Entrants
6.9.6 Threat of Substitutes
6.9.7 Regulations in the Generics Industry
6.10 Key Market Drivers and Success Factors
7 Global Generic Oncology Drug Market: Performance of Key Regions
7.1 North America
7.2 Europe
7.3 Asia Pacific
7.4 Middle East and Africa
7.5 Latin America
8 Global Generic Oncology Drug Market: Competitive Landscape
8.1 Market Structure
8.2 Market Breakup by Key Players
8.3 Key Player Profiles
9 Generic Oncology Drug Manufacturing Process
9.1 Product Overview
9.2 Detailed Process Flow (Tablets)
9.3 Detailed Process Flow (Injectable)
9.4 Various Types of Unit Operations Involved
9.5 Mass Balance and Raw Material Requirements
10 Project Details, Requirements and Costs Involved
10.1 Land Requirements and Expenditures
10.2 Construction Requirements and Expenditures
10.3 Plant Machinery
10.4 Machinery Pictures
10.5 Raw Material Requirements and Expenditures
10.6 Packaging Requirements and Expenditures
10.7 Transportation Requirements and Expenditures
10.8 Utility Requirements and Expenditures
10.9 Manpower Requirements and Expenditures
10.10 Other Capital Investments
11 Loans and Financial Assistance
12 Project Economics
12.1 Capital Cost of the Project
12.2 Techno-Economic Parameters
12.3 Product Pricing and Margins Across Various Levels of the Supply Chain
12.4 Taxation and Depreciation
12.5 Income Projections
12.6 Expenditure Projections
12.7 Financial Analysis
12.8 Profit Analysis

Figure 1: Global: Generic Drug Market: Major Drivers and Challenges
Figure 2: Global: Generic Drug Market: Sales Value Trends (in Billion US$), 2017-2022
Figure 3: Global: Generic Drug Market Forecast: Sales Value Trends (in Billion US$), 2023-2028
Figure 4: Global: Generic Drug Market: Breakup by Region (in %), 2022
Figure 5: Global: Generic Oncology Drug Industry Overview
Figure 6: Global: Generic Oncology Drug Market: Sales Value Trends (in Billion US$), 2017-2022
Figure 7: Global: Generic Oncology Drug Market Forecast: Sales Value Trends (in Billion US$), 2023-2028
Figure 8: Global: Generic Oncology Drug Market: Breakup by Region (in %), 2022
Figure 9: Global: Generic Oncology Drug Industry: SWOT Analysis
Figure 10: Global: Generic Oncology Drug Industry: Value Chain Analysis
Figure 11: Global: Generic Oncology Drug Industry: Porter’s Five Forces Analysis
Figure 12: North America: Generic Oncology Drug Market (in Million US$), 2017, 2023 & 2028
Figure 13: Asia Pacific: Generic Oncology Drug Market (in Million US$), 2017, 2023 & 2028
Figure 14: Europe: Generic Oncology Drug Market (in Million US$), 2017, 2023 & 2028
Figure 15: Latin America: Generic Oncology Drug Market (in Million US$), 2017, 2023 & 2028
Figure 16: Middle East and Africa: Generic Oncology Drug Market (in Million US$), 2017, 2023 & 2028
Figure 17: Generic Oncology Drug Industry: Profit Margins at Various Levels of the Supply Chain
Figure 18: Generic Oncology Drug Manufacturing: Production Cost Breakup (in %)
Figure 19: Generic Oncology Drug Manufacturing Plant: Detailed Process Flow
Figure 20: Generic Oncology Drug Manufacturing Process: Conversion Rate of Feedstocks
Figure 21: Generic Oncology Drug Manufacturing Plant: Proposed Plant Layout
Figure 22: Generic Oncology Drug Manufacturing Plant: Breakup of Capital Costs (in %)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ ジェネリック腫瘍治療薬の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測(Generic Oncology Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ジェネリック注射剤の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • ジェネリック医薬品の日本市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • ケツルアズキの世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測
  • キマメ（ピジョンピー）の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測

    • ◆H&Iグローバルリサーチのお客様（例）◆